These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5577811)

  • 1. [Tablets of 7-(3'-(methylhydroxyethylamino)-2'-hydroxypropyl)-theophylline nicotinate with delayed action. I. Moderation of the release of the active substance by some additives].
    Pawlak E; Chodkowska-Granicka B; Surowiecki J
    Acta Pol Pharm; 1971; 28(1):43-7. PubMed ID: 5577811
    [No Abstract]   [Full Text] [Related]  

  • 2. [Glycerin ester of higher fatty acids as pharmaceutic aids. 6. Release of an imbedded drug from tablets containing higher fatty acids and their esters].
    Chalabala M; Starha L
    Pharmazie; 1970 Sep; 25(9):535-8. PubMed ID: 5486680
    [No Abstract]   [Full Text] [Related]  

  • 3. Tablets of 7-(3'-(methylhydroxylethylamino)-2'-hydroxypropyl)-theophylline nicotinate with prolonged action. II. Retardation of the drug release by polymer coating of tablets.
    Chodkowska-Granicka B; Pawlak Z; Pawlak E; Surowiecki J
    Acta Pol Pharm; 1972; 29(6):618-22. PubMed ID: 4670139
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the effect of some pharmaceutic aids on the physical properties of tablets].
    Sümegi G; Kedvessy G
    Pharmazie; 1970 Sep; 25(9):544-6. PubMed ID: 5486682
    [No Abstract]   [Full Text] [Related]  

  • 5. [Progress in pharmaceutical technology during 1970 and 1971].
    Chalabala M; Heliová M; Lichnerová I; Rak J; Malý J; Slaný J; Starha J
    Cesk Farm; 1972 Nov; 21(9):411-31. PubMed ID: 4575871
    [No Abstract]   [Full Text] [Related]  

  • 6. Controlled release of theophylline from inert matrices: effect of channeling material on release rate.
    Ghaly ES; Malavé MI; Rivera WJ; Martí A
    P R Health Sci J; 1993 Dec; 12(4):255-8. PubMed ID: 8140202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
    Kranz H; Wagner T
    Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Carboxymethyldextran as pharmaceutic aid in tablets. II. Properties of tablets prepared by means of carboxymethyldextran].
    Chwialkowska L; Krówczyński L
    Acta Pol Pharm; 1968; 25(6):583-90. PubMed ID: 5730630
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmaceutical heterogeneous systems. II. Study of hydrolysis of aspirin in combination with fatty acid tablet lubricants.
    Maulding HV; Zoglio MA; Johnston EJ
    J Pharm Sci; 1968 Nov; 57(11):1873-6. PubMed ID: 5725915
    [No Abstract]   [Full Text] [Related]  

  • 10. [Control of drug release from coated parenteral matrix-retard tablets using softening agents].
    Korsatko W; Wabnegg B
    Pharmazie; 1983 Sep; 38(9):608-11. PubMed ID: 6647533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on the changes in the cerebral blood volume under the influence of 3-(methylhydroxyethylamino)-2-hydroxypropyl-theophylline nicotinate with the aid of cranial rheography].
    SCHREIBER H
    Med Klin; 1960 Mar; 55():509-11. PubMed ID: 14443546
    [No Abstract]   [Full Text] [Related]  

  • 12. [Influence of various factors on the velocity of drug release from depot tablets. 2. Isoniazid-depot tablets].
    Naplatanova D; Tomassini L
    Pharmazie; 1974 May; 29(5):321-3. PubMed ID: 4848951
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thermoplastic granulation as an alternative method for the preparation of hydrophilic-lipophilic oral matriix tablets].
    Dvorácková K; Rabisková M; Masteiková R; Vocilková L
    Ceska Slov Farm; 2007 Jun; 56(3):129-34. PubMed ID: 17867525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Binding activity of some adjuvants and their influence on the physical properties of granules and tablets].
    Delonca MH; Joachim MJ; Munerot MJ; Freida MA
    Farmaco Prat; 1973; 28(1):3-25. PubMed ID: 4683656
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of certain tablet formulation factors on the antimicrobial activity of tetracycline hydrochloride and chloramphenicol. 3. Effect of lubricants.
    Asker A; el-Nakeeb M; Motawi M; el-Gindy N
    Pharmazie; 1973 Jul; 28(7):476-8. PubMed ID: 4767501
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of composition of pharmaceutic aids on the disintegration of tablets].
    Borzunov EE; Shevchenko SM
    Farmatsiia; 1969; 18(1):20-3. PubMed ID: 5770765
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of polyvinylalcohol (PVA) in obtaining sugar-containing or sugar-free dragee coatings].
    Moldenhauer H; Kala H; Zessin G; Nauenburg G
    Pharmazie; 1974 Jan; 29(1):26-31. PubMed ID: 4362359
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
    Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
    Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Peroral drugs with prolonged action. I. Tablets with soluble drug incorporated into stearic acid].
    Chalabala M; Starha L
    Cesk Farm; 1968 Jul; 17(6):290-2. PubMed ID: 5699394
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolongation of theophylline derivative release with cellulose acetate based tablets].
    Guyonnet T; Brossard C; Lefort des Ylouses D
    J Pharm Belg; 1990; 45(2):111-9. PubMed ID: 2355304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.